Frequency Therapeutics, Astellas sign deal to tune of $625M
July 17, 2019 at 05:59 AM EDT
Japanese firm Astellas Health will join Woburn's Frequency Therapeutics as it steers its first treatment for the most common cause of hearing loss through the clinic.
